You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mFOLFIRINOX

Showing 1 - 25 of 98
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • mFOLFIRINOX plus radiotherapy
  • (no location specified)
Nov 21, 2023

Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

Recruiting
  • Adenocarcinoma, Pancreatic Ductal
  • Autogene cevumeran
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2023

Pancreatic Cancer Trial in Nanjing (Cadonilimab+mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Nov 23, 2023

Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • Nanjing, Jiangsu, China
    The Affiliated Hospital of Nanjing University Medical School
Nov 21, 2023

Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • BNT321 Dose Level 1
  • +3 more
  • (no location specified)
Sep 29, 2023

Pancreatic Ductal Adenocarcinoma Trial in Cleveland (Ivosidenib, mFOLFIRINOX)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 15, 2022

Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Sep 23, 2022

Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma
  • mFOLFIRINOX
  • Gemcitabine / Nab-paclitaxel
  • Hamilton, Ontario, Canada
    Juravinski Hospital
Aug 5, 2022

Pancreatic Adenocarcinoma, Pancreatic Cancer Non-resectable Trial in Seoul (SBRT+mFOLFIRINOX, mFOLFIRINOX)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Cancer Non-resectable
  • SBRT+mFOLFIRINOX
  • mFOLFIRINOX
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 24, 2022

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Pancreatic Cancer Trial in United States (mFOLFIRINOX, Ramucirumab, Placebo)

Active, not recruiting
  • Pancreatic Cancer
  • mFOLFIRINOX
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Feb 14, 2022

Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Shanghai (Nab paclitaxel plus

Recruiting
  • Borderline Resectable Pancreatic Cancer
  • Locally Advanced Pancreatic Adenocarcinoma
  • Nab paclitaxel plus gemcitabine
  • mFOLFIRINOX
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Jan 27, 2022

Pancreatic Cancer Trial in Seoul (Chlorphenesin Carbamate, Hydroxychloroquine)

Recruiting
  • Pancreatic Cancer
  • Chlorphenesin Carbamate, Hydroxychloroquine
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 23, 2022

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • mFOLFIRINOX
  • +7 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Locally-advanced Rectal Cancer Trial in Lyon, Villejuif (mFOLFIRINOX, Pelvic radiotherapy LCRT, Capecitabine)

Not yet recruiting
  • Locally-advanced Rectal Cancer
  • mFOLFIRINOX
  • +6 more
  • Lyon, Rhöne, France
  • +1 more
Jun 12, 2023

Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)

Not yet recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023

Pancreatic Tumor Trial in Brussels (mFOLFIRINOX or gemcitabine-nabpaclitaxel)

Not yet recruiting
  • Pancreatic Neoplasm
  • mFOLFIRINOX or gemcitabine-nabpaclitaxel
  • Brussels, Belgium
    Hopital Erasme
Oct 15, 2021

Colorectal Cancer Stage IV Trial in Sao Paulo (mFOLFIRINOX)

Recruiting
  • Colorectal Cancer Stage IV
  • mFOLFIRINOX
  • Sao Paulo, SP, Brazil
    ICESP
Apr 28, 2022

Pancreatic Adenocarcinoma Trial in Evanston (5 Fluorouracil, Leucovorin, Irinotecan)

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • 5 Fluorouracil
  • +3 more
  • Evanston, Illinois
    NorthShore University HealthSystem
Nov 4, 2021

Colon Cancer Trial (mFOLFIRINOX-FOLFIRI intensified chemo, FOLFOX or CAPOX adjuvant chemo)

Not yet recruiting
  • Colon Cancer
  • mFOLFIRINOX-FOLFIRI intensified chemotherapy
  • FOLFOX or CAPOX adjuvant chemotherapy
  • (no location specified)
Sep 6, 2022

Unresectable Pancreatic Cancer Trial in Sendai-shi, Miyagi, Shinjuku-ku, Tokyo, Yokohama-shi, Kanagawa (Suizenji, Nal-IRI/FL,

Recruiting
  • Unresectable Pancreatic Cancer
  • Suizenji
  • +3 more
  • Sendai-shi, Miyagi, Japan
  • +2 more
Jan 31, 2023

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

Not yet recruiting
  • Advanced Esophageal Adenocarcinoma
  • +14 more
  • (no location specified)
Jan 3, 2023

Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic body radiotherapy (SBRT)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Sep 15, 2023

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • mFOLFIRINOX adjuvant chemotherapy
  • mFOLFOX6/XELOX adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 12, 2023

Adenocarcinoma of the Pancreas Trial in Morgantown (Hydroxychloroquine sulfate)

Recruiting
  • Adenocarcinoma of the Pancreas
  • Hydroxychloroquine sulfate
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
Aug 2, 2021